Overview

Two-Dose Methotrexate for Ectopic Pregnancy

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
Phase:
Phase 3
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
Bill and Melinda Gates Foundation
Treatments:
Methotrexate